Flexion Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 3.22, indicating more challenging environment then in the second quarter 2021, but still, it is a far cry from any concerns. Flexion Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2021 quarter, has increased to 113 days, from 110 days, in the Jun 30 2021 quarter.

If we take a look into Healthcare sector 531 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2021 from 3226 to 3328.

What is Receivable Turnover Ratio?
What is Flexion Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FLXN Receivables Turnover Ratio	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Receivable Change	5.29 %	63.06 %	0.01 %	-19.1 %	-4.83 %
Y / Y Revenue Change	-9.88 %	82.35 %	22.17 %	11.23 %	8.62 %
Receivable Turnover Ratio (TTM)	3.22	3.33	3.28	3.12	2.84
FLXN's Total Ranking	# 3328	# 3226	# 2122	# 2122	# 3088
Accounts Receivable average collection period days	113	110	111	117	129
Seq. Receivable Change	-16.3 %	15.58 %	1.13 %	7.62 %	29.62 %
Seq. Revenue Change	-24.31 %	14.58 %	-6.54 %	11.18 %	53.16 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 189
Healthcare Sector	# 532
Overall Market	# 3328

Receivable Turnover Ratio Statistics
High	Average	Low
3.33	3.01	2.74
(Jun 30 2021)		(Jun 30 2020)

FLXN Company Profile • Back to FLXN Efficiency Comparisons • Compare FLXN Receivables Turnover Ratio to its Competitors

Financial Statements
Flexion Therapeutics Inc 's Accounts Receivable	$ 29 Millions	Visit FLXN's Balance sheet
Flexion Therapeutics Inc 's Sales TTM	$ 100 Millions	Visit FLXN's Income Statement
Sources of FLXN's Revenues		Visit FLXN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FLXN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FLXN's Growth Rates	FLXN's Roa	FLXN's Inventory Turnover Ratio	FLXN's Dividend Comparisons
FLXN's Profitability Ratios	FLXN's Roi	FLXN's Asset Turnover Ratio	FLXN's Dividend Growth
FLXN's Valuation Ratios	FLXN's Roe	FLXN's Financial Strength Ratios	FLXN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2021	Receivable at quarter ending Sep 30 2021
Zogenix Inc	9.37	$ 63.585 Millions	$ 6.783 Millions
Strata Skin Sciences Inc	9.37	$ 27.637 Millions	$ 2.951 Millions
Cadre Holdings inc	9.34	$ 98.654 Millions	$ 10.558 Millions
Cannabis Global Inc.	9.26	$ 1.601 Millions	$ 0.173 Millions
Evolus Inc	9.25	$ 85.593 Millions	$ 9.250 Millions
Solana Company	9.22	$ 0.454 Millions	$ 0.049 Millions
Viemed Healthcare Inc	9.21	$ 116.302 Millions	$ 12.621 Millions
Imac Holdings Inc	9.21	$ 13.480 Millions	$ 1.464 Millions
Talphera Inc	9.17	$ 3.554 Millions	$ 0.388 Millions
Pacira Biosciences inc	9.17	$ 513.313 Millions	$ 55.990 Millions
Procyon Corporation	9.11	$ 4.663 Millions	$ 0.512 Millions
Ontrak Inc	9.10	$ 103.052 Millions	$ 11.319 Millions
Global Blood Therapeutics Inc.	9.09	$ 179.945 Millions	$ 19.801 Millions
Sunwin Stevia International Inc.	9.02	$ 30.282 Millions	$ 3.356 Millions
Evoke Pharma Inc	8.96	$ 1.281 Millions	$ 0.143 Millions
Becton Dickinson And Company	8.93	$ 19,965.000 Millions	$ 2,236.000 Millions
Veru Inc	8.92	$ 61.260 Millions	$ 6.871 Millions
Iradimed Corporation	8.91	$ 38.488 Millions	$ 4.319 Millions
Radnet Inc	8.85	$ 1,296.720 Millions	$ 146.497 Millions
Quanterix Corporation	8.83	$ 106.400 Millions	$ 12.049 Millions
Angiodynamics Inc	8.81	$ 297.765 Millions	$ 33.814 Millions
Silk Road Medical Inc	8.80	$ 94.343 Millions	$ 10.725 Millions
Heska Corporation	8.76	$ 249.993 Millions	$ 28.536 Millions
Acadia Pharmaceuticals Inc	8.74	$ 474.394 Millions	$ 54.286 Millions
Axonics Inc	8.72	$ 161.938 Millions	$ 18.565 Millions
Edwards Lifesciences Corporation	8.70	$ 5,094.500 Millions	$ 585.575 Millions
Zai Lab Limited	8.69	$ 115.235 Millions	$ 13.257 Millions
Adamas Pharmaceuticals Inc	8.69	$ 88.189 Millions	$ 10.153 Millions
Resmed Inc	8.67	$ 4,746.857 Millions	$ 547.376 Millions
Henry Schein Inc	8.66	$ 12,236.224 Millions	$ 1,412.790 Millions

Date modified: 2026-10-07T00:41:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.